Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on October 7, 2026

Oct. 7, 2026

SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study

Indeterminate GlobeNewswire

Oct. 7, 2026

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

Indeterminate GlobeNewswire

Oct. 7, 2026

RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

Indeterminate GlobeNewswire

Oct. 7, 2026

Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia

Indeterminate GlobeNewswire

Oct. 7, 2026

Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib

Indeterminate GlobeNewswire

Oct. 7, 2026

Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Conference

Indeterminate GlobeNewswire

Oct. 7, 2026

Fusemachines Launches fuse.ai to Showcase the Future of AI Twins in the Workplace

Indeterminate GlobeNewswire

Oct. 7, 2026

SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture

Indeterminate GlobeNewswire

Oct. 7, 2026

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

Indeterminate GlobeNewswire

Oct. 7, 2026

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Oct. 7, 2026

BookingCentral Launches AI Connector, Letting Rental and Tour Operators Ask Claude or ChatGPT About Their Fleet, Bookings and Customers in Plain English

Indeterminate GlobeNewswire

Oct. 7, 2026

Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field

Indeterminate GlobeNewswire

Oct. 7, 2026

EXL schedules third quarter 2026 financial results conference call

Indeterminate GlobeNewswire

Oct. 7, 2026

Safe Pro Expects Record 2,300% Revenue Growth in Q3 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping

Indeterminate GlobeNewswire

Oct. 7, 2026

SEON Appoints Ken Talanian as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 7, 2026

Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide

Indeterminate GlobeNewswire

Oct. 7, 2026

Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home

Indeterminate GlobeNewswire

Oct. 7, 2026

Clearsense Introduces Cloud Medical Image Archive to Reduce Infrastructure and Storage Costs

Indeterminate GlobeNewswire

Oct. 7, 2026

ZeroMe Launches OffsetC App to Bring Transparency and Personal Agency to Carbon Offsetting

Indeterminate GlobeNewswire

Oct. 7, 2026

AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire